Rationale for the short-term use of luteinising hormone-releasing hormone analogues in the treatment of uterine myomata.
作者信息
Stovall T G
机构信息
Department of Obstetrics and Gynecology, University of Tennessee, Memphis.
出版信息
Horm Res. 1989;32 Suppl 1:134-6. doi: 10.1159/000181328.
PMID:2693324
Abstract
Luteinising hormone-releasing hormone (LHRH) analogue administration can reduce the size of uterine leiomyomata and its pre-operative use prior to myomectomy or hysterectomy is discussed. It is concluded that pre-operative use of LHRH analogues does have a role in gynaecological surgery.
摘要
Zotero 插件